4,4',6-trimethylangelicin has been researched along with alpha-aminopyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atlante, A; Bobba, A; Casavola, V; Favia, M; Guerra, L; Reshkin, SJ | 1 |
| Bear, CE; Casavola, V; Laselva, O; Molinski, S | 1 |
2 other study(ies) available for 4,4',6-trimethylangelicin and alpha-aminopyridine
| Article | Year |
|---|---|
Characterization of mitochondrial function in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.
Topics: Aminopyridines; Benzodioxoles; Cells, Cultured; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Energy Metabolism; Furocoumarins; Humans; Mitochondrial Diseases; Mutation; Respiratory System | 2016 |
The investigational Cystic Fibrosis drug Trimethylangelicin directly modulates CFTR by stabilizing the first membrane-spanning domain.
Topics: Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Furocoumarins; HEK293 Cells; Humans; Molecular Structure; Protein Domains | 2016 |